Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Acumen Pharmaceuticals
Acumen Pharmaceuticals
(ABOS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Histone-arginine methyltransferase carm1
healthy volunteers/patients
,
tissue adhesions
Surlorian
healthy volunteers/patients
,
coronary artery disease
,
esophageal neoplasms
,
obesity
,
overweight
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
chronic urticaria
,
urticaria
,
type 1 diabetes mellitus
,
triple negative breast neoplasms
,
ovarian epithelial carcinoma
,
gastrointestinal endoscopy
,
renal cell carcinoma
,
cholangiocarcinoma
,
neoplasms
,
endometrial neoplasms
,
carcinosarcoma
,
hypertension
,
sepsis
,
acute kidney injury
,
non-small-cell lung carcinoma
,
breast neoplasms
,
covid-19
,
prostatic neoplasms
,
ovarian neoplasms
,
small cell lung carcinoma
,
carcinoma
,
neoplasm metastasis
,
stomach neoplasms
,
urinary bladder neoplasms
,
lung neoplasms
,
human influenza
,
asthma
,
esophageal squamous cell carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
hypertriglyceridemia
,
gastroesophageal reflux
,
esophagitis
,
respiratory distress syndrome
,
respiratory tract infections
,
infections
,
coronavirus infections
,
respiratory insufficiency
,
severe acute respiratory syndrome
,
virus diseases
,
exercise-induced asthma
,
bronchial spasm
,
exercise-induced allergies
,
type 2 diabetes mellitus
,
diabetes mellitus
,
lung diseases
,
chronic obstructive pulmonary disease
,
obstructive lung diseases
,
renal insufficiency
,
kidney function tests
,
thrombosis
,
thromboembolism
,
atherosclerosis
,
systemic lupus erythematosus
,
post-traumatic stress disorders
,
combat disorders
SABIRNETUG
alzheimer disease
,
memory disorders
,
cognitive dysfunction
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use